A molecular subtyping strategy that classifies SCLC cells into three groups (SCLC-A, N, and P) based on the expression of neural lineage-defining transcription factors (ASCL1, NEUROD1, or POU2F3) has recently been proposed46. This evidence concerns the gene ASCL1 and small cell lung carcinoma.